Biotest AG/ DE0005227201 /
17/12/2018 00:00:00 | Chg. - | Volume | Bid- | Demandez à- | Capitalisation boursière | Dividende Y. | Rapport P/E |
---|---|---|---|---|---|---|---|
27.20EUR | - | 5 Chiffrre d'affaires: - |
-Bid taille: - | -Ask la taille: - | 1.61 Mrd.EUR | 0.10% | - |
GlobeNewswire
03:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Dir...
GlobeNewswire
02:45
Novotech Liver Cancer Research Landscape Report Finds 1,700 Trials Initiated Globally
GlobeNewswire
01:44
ROSEN, LEADING INVESTOR COUNSEL, Encourages UiPath, Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
01:35
ROSEN, LEADING INVESTOR COUNSEL, Encourages NIKE, Inc. Investors to Secure Counsel Before Important ...
GlobeNewswire
22/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MacroGenics, In...
GlobeNewswire
22/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Masimo Corporati...
GlobeNewswire
22/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FutureFuel Corp....
GlobeNewswire
22/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bolt Biotherapeu...
GlobeNewswire
22/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharma...
GlobeNewswire
22/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Hesai Group - HS...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page